BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28939501)

  • 1. Reprogramming of somatic cells to induced neural stem cells.
    Shahbazi E; Mirakhori F; Ezzatizadeh V; Baharvand H
    Methods; 2018 Jan; 133():21-28. PubMed ID: 28939501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases.
    Shen T; Pu J; Zheng T; Zhang B
    Neurosci Bull; 2015 Oct; 31(5):589-600. PubMed ID: 26077704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications.
    Erharter A; Rizzi S; Mertens J; Edenhofer F
    FEBS Lett; 2019 Dec; 593(23):3353-3369. PubMed ID: 31663609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion.
    Velychko S; Kang K; Kim SM; Kwak TH; Kim KP; Park C; Hong K; Chung C; Hyun JK; MacCarthy CM; Wu G; Schöler HR; Han DW
    Cell Rep; 2019 Apr; 27(1):30-39.e4. PubMed ID: 30943410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative transcriptome analysis in induced neural stem cells reveals defined neural cell identities in vitro and after transplantation into the adult rodent brain.
    Hallmann AL; Araúzo-Bravo MJ; Zerfass C; Senner V; Ehrlich M; Psathaki OE; Han DW; Tapia N; Zaehres H; Schöler HR; Kuhlmann T; Hargus G
    Stem Cell Res; 2016 May; 16(3):776-81. PubMed ID: 27153350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
    Li R; Bai Y; Liu T; Wang X; Wu Q
    Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status.
    Kim SM; Lim KT; Kwak TH; Lee SC; Im JH; Hali S; In Hwang S; Kim D; Hwang J; Kim KP; Chung HJ; Kim JB; Ko K; Chung HM; Lee HT; Schöler HR; Han DW
    Stem Cell Res; 2016 Mar; 16(2):460-8. PubMed ID: 26930613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting involvement of polycomb repressive complex 2 in direct conversion of mouse fibroblasts into induced neural stem cells.
    Yaqubi M; Mohammadnia A; Fallahi H
    Stem Cell Res Ther; 2015 Mar; 6(1):42. PubMed ID: 25890371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats.
    Yao H; Gao M; Ma J; Zhang M; Li S; Wu B; Nie X; Jiao J; Zhao H; Wang S; Yang Y; Zhang Y; Sun Y; Wicha MS; Chang AE; Gao S; Li Q; Xu R
    PLoS One; 2015; 10(9):e0137211. PubMed ID: 26352672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced neural stem cells: methods of reprogramming and potential therapeutic applications.
    Ruggieri M; Riboldi G; Brajkovic S; Bucchia M; Bresolin N; Comi GP; Corti S
    Prog Neurobiol; 2014 Mar; 114():15-24. PubMed ID: 24246715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct reprogramming of fibroblasts into neural stem cells by defined factors.
    Han DW; Tapia N; Hermann A; Hemmer K; Höing S; Araúzo-Bravo MJ; Zaehres H; Wu G; Frank S; Moritz S; Greber B; Yang JH; Lee HT; Schwamborn JC; Storch A; Schöler HR
    Cell Stem Cell; 2012 Apr; 10(4):465-72. PubMed ID: 22445517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor.
    Ring KL; Tong LM; Balestra ME; Javier R; Andrews-Zwilling Y; Li G; Walker D; Zhang WR; Kreitzer AC; Huang Y
    Cell Stem Cell; 2012 Jul; 11(1):100-9. PubMed ID: 22683203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells.
    Zheng J; Choi KA; Kang PJ; Hyeon S; Kwon S; Moon JH; Hwang I; Kim YI; Kim YS; Yoon BS; Park G; Lee J; Hong S; You S
    Biochem Biophys Res Commun; 2016 Jul; 476(1):42-8. PubMed ID: 27207831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced Stem Cells as a Novel Multiple Sclerosis Therapy.
    Xie C; Liu YQ; Guan YT; Zhang GX
    Curr Stem Cell Res Ther; 2016; 11(4):313-20. PubMed ID: 25732737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.
    Smith DK; He M; Zhang CL; Zheng JC
    Prog Neurobiol; 2017 Oct; 157():212-229. PubMed ID: 26844759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.
    Winiecka-Klimek M; Smolarz M; Walczak MP; Zieba J; Hulas-Bigoszewska K; Kmieciak B; Piaskowski S; Rieske P; Grzela DP; Stoczynska-Fidelus E
    PLoS One; 2015; 10(11):e0141688. PubMed ID: 26535892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.